Welcome

Welcome to the Wagner lab!

The group is dedicated to the development, and preclinical as well as clinical testing, of HIV candidate vaccines. According to the necessity of rational vaccine design the group is focussing on various aspects of epidemiology, viral pathogenesis and morphogenesis, HIV replication, and vaccine manufacturing, including preclinical and clinical monitoring of antigen-specific B- and T-cell responses. The group is fully financed by national and international grants such as the Bavarian Research Foundation (Bayerische Forschungsstiftung), the German Ministry of Education and Research (BMBF), the European Union and the Bill & Melinda Gates Foundation.

alt text
startbild

News

17.06.2020

COVID-19-Immunität im Landkreis Tirschenreuth – Start der Antikörpertestung – Erwachsene und Kinder werden zur Teilnahme eingeladen

Regensburg, 2020-06-17: Die Wissenschaftler der Universitätskliniken Regensburg und Erlangen haben den 29. Juni als Start für die vom Staatsministerium für Wissenschaft und Kunst (StMWK) in Auftrag gegebene Antikörpertestung im... > more

08.05.2020

Start der Antikörperstudie zu bislang unerkannten COVID19-Infektionen im Landkreis Tirschenreuth

Regensburg, 2020-05-08: Bayern startet eine neue Studie zu COVID19-Infektionen: Mit Hilfe einer zufälligen Stichprobenanalyse im Landkreis Tirschenreuth wollen Wissenschaftler der Universität Regensburg sowie der... > more

14.08.2018

New project granted

Regensburg, 2018-08-14: New project granted: The Wagner lab will be partner in the project "Clinical trial of a DIOS Trivalent Haemorrhagic Fever Vaccine" (HFVac3). Based on the excellent outcomes of the two predecessor... > more

18.05.2018

New project granted

Regensburg, 2018-05-18: New project granted: The Wagner lab will be partner in the project "A therapeutic vaccine to eradicate pre-malignant HPV16 and HPV18 infection and prevent cancer" (THERIN). In cooperation with... > more

17.03.2017

New project granted

Regensburg, 2017-03-17: The Wagner lab will participate in the "Trivalent Lassa, Ebola and Marburg viral vaccine" (Tri-LEMvac) consortium, funded by innovate UK and coordinated by Prof. Jonathan Heeney from Darwin... > more

Meetings

Upcoming Meetings
> more

Jobs

We permanently offer several opportunities for students to conduct research projects in the context of `Forschungs- und Schwerpunktpraktika´.
> more